Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis.
Conclusions: The prevalence of psychiatric disorders is higher among PsO patients than the general population, and the incremental burden of treated anxiety/depression is substantial. Further research is needed, but PsO treatments that improve psychiatric symptoms such as anxiety/depression may benefit patients and reduce their economic burden.
PMID: 31262226 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Anxiety | Databases & Libraries | Depression | Economics | Generalized Anxiety Disorder (GAD) | Health Management | Healthcare Costs | Insurance | Psoriasis | Psychiatry